Condition: Cutaneous Melanoma · Sponsor: Herlev and Gentofte Hospital
The aim of this study is to evaluate a new method of follow-up for patients with low and intermediate risk (stages IA-IIA) melanoma. The investigators will compare different tools for patient support and education combined with clinician supported skin self-examination (SSE) to the current standard-of-care. The hypothesis is that meta-cognitive strategies and clinician supported SSE can lower fear of cancer recurrence (FCR) and promote effective SSE on a regular basis without compromising the detection of new primary melanomas and/or metastases.
This description comes directly from the study's public registry record.
Sara M Hansen, MD · +4538681296 · sara.moelgaard.hansen@regionh.dk
Lisbet R Hölmich, Professor · +4538681243 · lisbet.rosenkrantz.hoelmich@regionh.dk
Always discuss trial participation with your own doctor first.
| Herlev and Gentofte Hospital | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05253872